Identification of gastroenteropancreatic neuroendocrine tumor patients with high liver tumor burden based on clinicopathological features

被引:0
作者
Jumai, Nuerailaguli [1 ]
Chen, Luohai [1 ]
Lin, Xiaoxuan [1 ]
He, Qiao [2 ]
Liu, Man [1 ]
Lin, Yuan [3 ]
Luo, Yanji [4 ]
Wang, Yu [5 ]
Chen, Min-hu [1 ]
Zhang, Xiangsong [2 ]
Zeng, Zhirong [1 ]
Zhang, Ning [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nucl Med, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou, Peoples R China
关键词
Neuroendocrine tumors; Liver metastasis; Tumor burden; Prognosis; NEURON-SPECIFIC ENOLASE; CELL LUNG-CANCER; PROGNOSTIC-FACTORS; LACTATE-DEHYDROGENASE; METASTASES; NEOPLASMS; SURVIVAL; CHEMOEMBOLIZATION; EPIDEMIOLOGY; PROGRESSION;
D O I
10.1186/s12885-025-14535-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Metastatic liver tumor burden (LTB) is a prognostic factor affecting the survival of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), but evaluation of the LTB usually depends on radiologic and functional imaging. This study aimed to develop a clinical model based on easily accessible clinicopathological markers to predict LTB level in GEP-NET patients. Methods: LTB was quantified based on Ga-68-DOTANOC PET/CT scan. The optimal cut-off value for high and low-LTB was determined based on our previous study. Serum levels of liver enzymes and tumor biomarkers were obtained within one week before PET/CT scan. The whole dataset was divided into training set and validation set. LASSO regression method was used to select predictors, and multivariate logistic regression was used to develop a clinical model which was further visualized by constructing a nomogram. Area under the curve (AUC) was applied to assess the accuracy of the constructed model. Results: We retrospectively enrolled 200 patients with well-differentiated GEP-NETs. Ki-67 index, GGT (gammaglutamyltransferase), LDH (lactate dehydrogenase), and NSE (neuron-specific enolase) were selected through the LASSO regression method, and a nomogram was built based on these variables. The predictive model yielded an AUC of 0.785 (95% CI, [0.708-0.862]) in the training set, and 0.783 (95% CI, [0.644-0.923]) in the validation set. Additionally, with the optimal cut-off values based on the nomogram total points, patients were categorized as LTBhigh (total points >= 26.2) and LTBlow (total points < 26.2) groups presenting significantly different OS. Conclusion: A clinically applicable nomogram incorporating four clinicopathological characteristics was constructed to predict GEP-NET patients with high-LTB. The nomogram may help clinicians identify patients with high-LTB and take optimal treatment measures to improve prognosis.
引用
收藏
页数:9
相关论文
共 40 条
[1]   LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951) [J].
Agarwala, Sanjiv S. ;
Keilholz, Ulrich ;
Gilles, Erard ;
Bedikian, Agop Y. ;
Wu, Jane ;
Kay, Richard ;
Stein, Cy A. ;
Itri, Loretta M. ;
Suciu, Stefan ;
Eggermont, Alexander M. M. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (10) :1807-1814
[2]  
Bonner JA, 2000, CLIN CANCER RES, V6, P597
[3]  
Caplin ME, 2014, NEW ENGL J MED, V371, P1556, DOI [10.1056/NEJMoa1316158, 10.1056/NEJMc1409757]
[4]   Semiautomatic Tumor Delineation for Evaluation of 64Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor Volume [J].
Carlsen, Esben Andreas ;
Johnbeck, Camilla Bardram ;
Loft, Mathias ;
Pfeifer, Andreas ;
Oturai, Peter ;
Langer, Seppo W. ;
Knigge, Ulrich ;
Ladefoged, Claes Nohr ;
Kjaer, Andreas .
JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (11) :1564-1570
[5]   The role of quantitative tumor burden based on [68Ga]Ga-DOTA-NOC PET/CT in well-differentiated neuroendocrine tumors: beyond prognosis [J].
Chen, Luohai ;
Jumai, Nuerailaguli ;
He, Qiao ;
Liu, Man ;
Lin, Yuan ;
Luo, Yanji ;
Wang, Yu ;
Chen, Min-hu ;
Zeng, Zhirong ;
Zhang, Xiangsong ;
Zhang, Ning .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (02) :525-534
[6]   Laboratory-Based Biomarkers and Liver Metastases in Metastatic Castration-Resistant Prostate Cancer [J].
Cotogno, Patrick M. ;
Ranasinghe, Lahiru K. ;
Ledet, Elisa M. ;
Lewis, Brian E. ;
Sartor, Oliver .
ONCOLOGIST, 2018, 23 (07) :791-797
[7]   Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States [J].
Dasari, Arvind ;
Shen, Chan ;
Halperin, Daniel ;
Zhao, Bo ;
Zhou, Shouhao ;
Xu, Ying ;
Shih, Tina ;
Yao, James C. .
JAMA ONCOLOGY, 2017, 3 (10) :1335-1342
[8]   Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors [J].
Dhall, Deepti ;
Mertens, Richard ;
Bresee, Catherine ;
Parakh, Rugvedita ;
Wang, Hanlin L. ;
Li, Marissa ;
Dhall, Girish ;
Colquhoun, Steven D. ;
Ines, Delma ;
Chung, Fai ;
Yu, Run ;
Nissen, Nicholas N. ;
Wolin, Edward .
HUMAN PATHOLOGY, 2012, 43 (04) :489-495
[9]   Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE) [J].
Garcia-Carbonero, R. ;
Capdevila, J. ;
Crespo-Herrero, G. ;
Diaz-Perez, J. A. ;
Martinez del Prado, M. P. ;
Alonso Orduna, V. ;
Sevilla-Garcia, I. ;
Villabona-Artero, C. ;
Beguiristain-Gomez, A. ;
Llanos-Munoz, M. ;
Marazuela, M. ;
Alvarez-Escola, C. ;
Castellano, D. ;
Vilar, E. ;
Jimenez-Fonseca, P. ;
Teule, A. ;
Sastre-Valera, J. ;
Benavent-Vinuelas, M. ;
Monleon, A. ;
Salazar, R. .
ANNALS OF ONCOLOGY, 2010, 21 (09) :1794-1803
[10]   Ki-67 predicts disease recurrence and poor prognosis in pancreatic neuroendocrine neoplasms [J].
Hamilton, Nicholas A. ;
Liu, Ta-Chiang ;
Cavatiao, Antonino ;
Mawad, Kareem ;
Chen, Ling ;
Strasberg, Steven S. ;
Linehan, David C. ;
Cao, Dengfeng ;
Hawkins, William G. .
SURGERY, 2012, 152 (01) :107-113